project id: TCGA-LUAD; case submitter id: TCGA-MP-A4SW; no matched normal low pass wgs: false; no matched normal targeted sequencing: false; no matched normal wgs: false; no matched normal wxs: false; selected normal low pass wgs: false; selected normal targeted sequencing: false; selected normal wgs: false; selected normal wxs: false; source center: 23; state: released; normal tumor genotype snp match: Yes; age at index: 53; days to birth: -19640; days to death: 1778; ethnicity: not reported; gender: male; race: white; vital status: Dead; year of birth: 1949; year of death: 2006; age at diagnosis: 19640; ajcc pathologic m: M0; ajcc pathologic n: N1; ajcc pathologic stage: Stage IIB; ajcc pathologic t: T2; ajcc staging system edition: 5th; classification of tumor: not reported; days to diagnosis: 0; icd 10 code: C34.1; last known disease status: not reported; morphology: 8140/3; primary diagnosis: Adenocarcinoma, NOS; prior malignancy: no; prior treatment: No; progression or recurrence: not reported; site of resection or biopsy: Upper lobe, lung; synchronous malignancy: No; tissue or organ of origin: Upper lobe, lung; tumor grade: Not Reported; year of diagnosis: 2002; treatment or therapy: no; alcohol history: Not Reported; cigarettes per day: 0.821917808219178; pack years smoked: 15.0; years smoked: 15.0; is ffpe: false; composition: Not Reported; days to collection: 3723; days to sample procurement: 0; initial weight: 130.0; portion submitter id: TCGA-MP-A4SW-01A-21; percent lymphocyte infiltration: 0.0; percent monocyte infiltration: 0.0; percent necrosis: 0.0; percent neutrophil infiltration: 0.0; percent normal cells: 10.0; percent stromal cells: 30.0; percent tumor cells: 60.0; percent tumor nuclei: 60.0;